Scientific Publications Database

Article Title: The Canadian Cancer Trials Group PA. 7 trial: Results from the safety run in of a randomized phase II study of gemcitabine (GEM) and nab-paclitaxel (Nab-P) versus GEM, nab-P, durvalumab (D), and tremelimumab (T) as first-line therapy in metastatic pancrea
Authors: Renouf, Daniel John; Dhani, Neesha C.; Kavan, Petr; Jonker, Derek J.; Wei, Alice Chia-chi; Hsu, Tina; Tang, Patricia A.; Graham, Barbara; Gallinaro, Lisa; Hasan, Tasnia; Li, Weiwei; Hart, Kate; Tu, Dongsheng; O'Callaghan, Christopher J.
Journal: JOURNAL OF CLINICAL ONCOLOGY Volume 36 Issue 4
Date of Publication:2018
Abstract:
.